RAFARMA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1105 USD | +8.33% |
|
+2.31% | -57.71% |
| 2021 | RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park | CI |
| 2021 | Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers | CI |
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 64 | 100.0 % | 10 | 100.0 % | -84.24% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 64 | 100.0 % | 10 | 100.0 % | -84.24% |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ilya Shpurov
CHM | Chairman | - | - |
Company contact information
Sector
This company's sector is not yet available
- Stock Market
- Equities
- RAFA Stock
- Company Rafarma Pharmaceuticals, Inc.
